Eli Lilly & Co. (LLY) Tops Q4 EPS by 7c, FY Guidance Tops Views
Tweet
Share
E-mail
Get Alerts LLY Hot Sheet
Price: $724.87 -1%
EPS Growth %: +51.9%
Financial Fact:
Other - net, expense (income): -27.2M
Today's EPS Names:
FRSB, DGICA, UXIN, More
EPS Growth %: +51.9%
Financial Fact:
Other - net, expense (income): -27.2M
Today's EPS Names:
FRSB, DGICA, UXIN, More
Join SI Premium – FREE
Eli Lilly & Co. (NYSE: LLY) reported Q4 EPS of $1.14, $0.07 better than the analyst estimate of $1.07. Revenue for the quarter came in at $6.16 billion versus the consensus estimate of $5.94 billion.
GUIDANCE:
Eli Lilly & Co. sees FY2018 EPS of $4.81-$4.91, versus the consensus of $4.68.
- sees revenue of $23-$23.5 billion (unchanged) vs consensus of $23.2 billion
For earnings history and earnings-related data on Eli Lilly & Co. (LLY) click here
.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gilead Sciences (GILD) Misses Q1 EPS by 288c
- Tenaris SA (TS) Tops Q1 EPS by 22c; offers outlook
- Data I/o Corp (DAIO) Misses Q2 EPS by 7c
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
